title: [The role of preserving therapy of invasive cancer of the urinary bladder].
abstract: Cystectomy in the treatment of invasive cancer of the urinary bladder is not the only therapeutic modality in this pathology. In selected patients an alternative exists--transurethral resection of the urinary bladder followed by adjuvant concurrent chemotherapy and radiotherapy. The preserving therapy can be recommended to patients over 60 years of age in the presence of a low-grade solitary tumor of a mobile wall of the urinary bladder respectable with preservation of the organ capacity.
authors.forename: B P
authors.initials: BP
authors.lastname: Matveev
authors.forename: S D
authors.initials: SD
authors.lastname: Sallum
authors.forename: B Sh
authors.initials: BSh
authors.lastname: Kamolov
authors.forename: K M
authors.initials: KM
authors.lastname: Figurin
authors.forename: V B
authors.initials: VB
authors.lastname: Matveev
authors.forename: M I
authors.initials: MI
authors.lastname: Volkova
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*